3.02
+0.13(+4.50%)
Currency In USD
| Previous Close | 2.89 |
| Open | 2.99 |
| Day High | 3.09 |
| Day Low | 2.81 |
| 52-Week High | 5.1 |
| 52-Week Low | 1.84 |
| Volume | 38,123 |
| Average Volume | 111,818 |
| Market Cap | 20.51M |
| PE | -5.12 |
| EPS | -0.59 |
| Moving Average 50 Days | 3.45 |
| Moving Average 200 Days | 2.97 |
| Change | 0.13 |
If you invested $1000 in NEXGEL, Inc. (NXGL) since IPO date, it would be worth $857.95 as of March 12, 2025 at a share price of $3.02. Whereas If you bought $1000 worth of NEXGEL, Inc. (NXGL) shares 3 years ago, it would be worth $1,745.66 as of March 12, 2025 at a share price of $3.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025
GlobeNewswire Inc.
Feb 13, 2025 2:00 PM GMT
LANGHORNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and c
NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
GlobeNewswire Inc.
Jan 22, 2025 2:00 PM GMT
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive year Management expects to generate at least $13
NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer
GlobeNewswire Inc.
Jan 02, 2025 2:00 PM GMT
LANGHORNE, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and c